Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Inventory (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Inventory for 11 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Inventory fell 21.91% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, down 21.91% year-over-year, with the annual reading at $11.4 million for FY2025, 5.82% down from the prior year.
  • Inventory for Q4 2025 was $8.7 million at Aytu Biopharma, down from $10.1 million in the prior quarter.
  • The five-year high for Inventory was $16.6 million in Q4 2021, with the low at $8.7 million in Q4 2025.
  • Average Inventory over 5 years is $12.7 million, with a median of $12.9 million recorded in 2022.
  • The sharpest move saw Inventory skyrocketed 151.98% in 2021, then tumbled 33.6% in 2022.
  • Over 5 years, Inventory stood at $16.6 million in 2021, then decreased by 21.79% to $13.0 million in 2022, then grew by 0.39% to $13.0 million in 2023, then fell by 14.74% to $11.1 million in 2024, then fell by 21.91% to $8.7 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $8.7 million, $10.1 million, and $11.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.